EW vs. PODD: Edwards Lifesciences vs. Insulet Stock Comparison

November 11, 2026

How do Edwards Lifesciences (EW) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Edwards Lifesciences (EW) and Insulet (PODD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Company profile comparison for Edwards Lifesciences (EW) and Insulet (PODD)
Profile Item	EW	PODD
Name	Edwards Lifesciences Corporation	Insulet Corporation
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Equipment
Market Capitalization	58.73 billion USD	10.16 billion USD
Currency	USD	USD
Exchange	NYSE	Nasdaq
Listing Date	March 27, 2000	May 15, 2007
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

PODD

GSPC

Edwards Lifesciences (EW) vs. Insulet (PODD), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Edwards Lifesciences (EW) and Insulet (PODD). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Edwards Lifesciences (EW) and Insulet (PODD). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
Total Return (1Y)	25.08%	-53.25%
Total Return (3Y, Annualized)	17.28%	-0.74%
Total Return (5Y, Annualized)	-2.77%	-14.02%

Risk Profile

Drawdown History

PODD

GSPC

Edwards Lifesciences (EW) vs. Insulet (PODD), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Edwards Lifesciences (EW) and Insulet (PODD). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
Volatility (1Y, Annualized)	25.58%	46.33%
Beta (5Y)	0.78	1.04
Max Drawdown (5Y)	-54.32%	-63.02%
Avg. Volume (3M)	3.69M	1.58M

Risk-Adjusted Performance

Risk-Return Positioning

EW and PODD are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
Sharpe Ratio (1Y)	0.81	-1.24
Sortino Ratio (1Y)	1.23	-1.51

Profitability

ROE (TTM)

Insulet (PODD) at 28.94% sits in the top ROE quartile, while Edwards Lifesciences (EW) at 9.33% is closer to the peer norm — stronger capital efficiency for PODD.

EW

Health Care Equipment & Services industry group

9.33%

Max: 47.61%
Q3: 14.36%
EW: 9.33%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

PODD

Health Care Equipment & Services industry group

28.94%

Max: 47.61%
PODD: 28.94%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both Edwards Lifesciences (EW) at 15.30% and Insulet (PODD) at 13.44% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

EW

Health Care Equipment & Services industry group

15.30%

Max: 29.35%
EW: 15.30%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

PODD

Health Care Equipment & Services industry group

13.44%

Max: 29.35%
PODD: 13.44%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Both Edwards Lifesciences (EW) at 30.15% and Insulet (PODD) at 22.54% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

EW

Health Care Equipment & Services industry group

30.15%

Max: 35.43%
EW: 30.15%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

PODD

Health Care Equipment & Services industry group

22.54%

Max: 35.43%
PODD: 22.54%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
ROE (TTM)	9.33%	28.94%
ROA (TTM)	8.77%	11.40%
Net Margin (TTM)	15.30%	13.44%
Operating Margin (TTM)	30.15%	22.54%
Gross Margin (TTM)	78.02%	71.88%

Growth

Revenue Growth

Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while Edwards Lifesciences (EW) at 11.55% is closer to the peer norm — faster top-line expansion for PODD.

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both Edwards Lifesciences (EW) at -73.74% and Insulet (PODD) at -39.79% post bottom-quartile EPS growth versus peers, pointing to weaker earnings momentum than typical rivals.

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
Revenue Growth (YoY)	11.55%	30.73%
Revenue Growth (3Y CAGR)	10.77%	27.54%
EPS Growth (YoY)	-73.74%	-39.79%
EPS Growth (3Y CAGR)	-9.14%	267.70%

Financial Strength

Current Ratio (MRQ)

Insulet (PODD) at 2.51 keeps current ratio within its industry’s typical mid-range, while Edwards Lifesciences (EW) at 4.60 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

EW

Health Care Equipment & Services industry group

4.60

Max: 7.59
EW: 4.60
Q3: 4.00
Median: 1.98
Q1: 1.37
Min: 0.30

PODD

Health Care Equipment & Services industry group

2.51

Max: 7.59
Q3: 4.00
PODD: 2.51
Median: 1.98
Q1: 1.37
Min: 0.30

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower industry quartile, while Insulet (PODD) at 0.66 runs a more typical debt-to-equity mix.

EW

Health Care Equipment & Services industry group

0.06

Max: 1.88
Q3: 0.91
Median: 0.58
Q1: 0.16
EW: 0.06
Min: 0.00

PODD

Health Care Equipment & Services industry group

0.66

Max: 1.88
Q3: 0.91
PODD: 0.66
Median: 0.58
Q1: 0.16
Min: 0.00

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
Current Ratio (MRQ)	4.60	2.51
Debt / Equity (MRQ)	0.06	0.66
Net Debt / EBITDA	-1.88	0.65

Dividends

Dividend Yield (TTM)

Neither Edwards Lifesciences (EW) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

EW

Health Care Equipment & Services industry group

0.00%

EW: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PODD

Health Care Equipment & Services industry group

0.00%

PODD: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Edwards Lifesciences (EW) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

EW

Health Care Equipment & Services industry group

0.00%

EW: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PODD

Health Care Equipment & Services industry group

0.00%

PODD: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
Dividend Yield (TTM)	0.00%	0.00%
Dividend Payout Ratio (TTM)	0.00%	0.00%

Valuation

P/E Ratio (TTM)

Insulet (PODD) at 23.94 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.

EW

Health Care Equipment & Services industry group

59.38

Max: 80.41
EW: 59.38
Q3: 47.62
Median: 29.93
Q1: 21.19
Min: 4.21

PODD

Health Care Equipment & Services industry group

23.94

Max: 80.41
Q3: 47.62
Median: 29.93
PODD: 23.94
Q1: 21.19
Min: 4.21

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

Insulet (PODD) at 3.19 is priced about in line with its industry on P/S ratio, while Edwards Lifesciences (EW) at 8.80 sits in the pricier quartile — EW costs more per dollar of sales.

EW

Health Care Equipment & Services industry group

8.80

EW: 8.80
Max: 8.80
Q3: 4.32
Median: 2.13
Q1: 1.10
Min: 0.03

PODD

Health Care Equipment & Services industry group

3.19

Max: 8.80
Q3: 4.32
PODD: 3.19
Median: 2.13
Q1: 1.10
Min: 0.03

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

Edwards Lifesciences (EW) at 5.41 is valued about in line with its industry on P/B ratio, while Insulet (PODD) at 6.44 carries an above-peer premium to book — PODD is pricier on assets.

EW

Health Care Equipment & Services industry group

5.41

Max: 11.68
Q3: 6.12
EW: 5.41
Median: 3.00
Q1: 1.73
Min: -1.31

PODD

Health Care Equipment & Services industry group

6.44

Max: 11.68
PODD: 6.44
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31

Edwards Lifesciences (EW) vs. Insulet (PODD): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Edwards Lifesciences (EW) and Insulet (PODD)
Metric	EW	PODD
P/E Ratio (TTM)	59.38	23.94
P/S Ratio (TTM)	8.80	3.19
P/B Ratio (MRQ)	5.41	6.44
Free Cash Flow Yield (TTM)	1.95%	1.12%